O'Shaughnessy Asset Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

O'Shaughnessy Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$73.71 - $87.86 $25,872 - $30,838	-351 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$77.92 - $102.4 $285,732 - $375,500	-3,667 Reduced 91.26%	351 $32,000
Q2 2021 Aug 09, 2021	BUY	$92.19 - $115.71 $553 - $694	6 Added 0.15%	4,018 $383,000
Q1 2021 May 14, 2021	BUY	$106.9 - $167.73 $855 - $1,341	8 Added 0.2%	4,012 $456,000
Q4 2020 Feb 11, 2021	BUY	$84.4 - $177.39 $337,178 - $708,673	3,995 Added 44388.89%	4,004 $554,000
Q2 2020 Aug 13, 2020	BUY	$46.91 - $78.22 $422 - $703	9 New	9 $1,000

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.34B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.